CGS 9896: A nonbenzodiazepine, nonsedating potential anxiolytic

This publication has 24 references indexed in Scilit:

• Multiple benzodiazepine receptors: Structures in the brain or structures in the mind? A critical review
  Life Sciences, 1983
• Discriminating between reward and performance: A critical review of intracranial self-stimulation methodology
  Neuroscience & Biobehavioral Reviews, 1983
• Photoaffinity labelling of the benzodiazepine receptor cannot be used to predict ligand efficacy
  Neuroscience Letters, 1983
• CGS 9896, a chloro‐derivative of the diazepam antagonist CGS 8216, exhibits anxiolytic activity in the pentylenetetrazol‐saline discrimination test
  Drug Development Research, 1982
• Molecular substrates of anxiety: Clues from the heterogeneity of benzodiazepine receptors
  Life Sciences, 1982
• A novel pyrazoloquinoline that interacts with brain benzodiazepine receptors: Characterization of some and properties of CGS 9896.
  Life Sciences, 1982
• Anxiolytic drugs selectively increase preferred duration of rewarding brain stimulation in a shuttlebox test
  Pharmacology Biochemistry and Behavior, 1982
• High affinity inhibition of [3H]-Flunitrazepam binding to brain benzodiazepine receptors by CGS 9896, a novel pyrazoloquinoline
  Biochemical and Biophysical Research Communications, 1982
• Agonist and antagonist benzodiazepine receptor interaction in vitro
  Nature, 1981
• Properties of 3H-diazepam binding to benzodiazepine receptors in rat cerebral cortex
  Life Sciences, 1977